The immune system of human body recognize some invaders such as bacteria, viruses, and external chemicals and attacks those to protect the body. However, sometimes the immune system attacks the healthy cells of body by considering them as foreign cells. Such a condition is called autoimmune disease. The autoimmune disease causes abnormal organ growth and changes in organ function. The genes of an individual with environmental exposure might be the major reason for autoimmune disease development. Some of the common autoimmune diseases among over 80 types of autoimmune diseases are type 1 diabetes, systemic lupus erythematosus, inflammatory bowel disease, rheumatoid arthritis. The curing therapy for autoimmune diseases is not yet available only relieving treatments are available for this diseases. Diagnosis of the autoimmune diseases can be done by the tests which involves antinuclear antibody test, antibody test, complete blood counts and some others.
Fill the form for an exclusive sample of this report : https://www.coherentmarketinsights.com/insight/request-sample/419
The growing incidences of autoimmune diseases and government initiatives to boost the autoimmune disease diagnostics market
According to American Autoimmune Related Disease Association (AARDA), in 2016, around 50 million people suffered from autoimmune diseases in the U.S. with 75% being women. Increasing incidence of autoimmune diseases, rising public awareness and government initiatives taken to spend the budget on diagnosis and care services for autoimmune diseases, are some of the factors which are driving the autoimmune disease diagnostics market. Many of the organizations and governments are funding the research and development program for autoimmune diseases, this will help to launch the new products in the market and definitely help in the growth of autoimmune disease diagnostics industry. For instance, the discovery of novel biomarkers, which has proven to be significant to improve the diagnosis of autoimmune diseases is also one of the major factor driving the autoimmune diseases diagnostic market.
Despite of all the driving factors for the autoimmune disease diagnostics market there are some restraints which slowing down the market such as, high rate of false results, slow turnaround time for test results and lack of experience and education of laboratory personnel in the diagnostics of certain autoimmune diseases.
Aging population and technological advancements in diagnosis of rheumatoid arthritis will be the cause of growth for rheumatoid arthritis segment
The global autoimmune disease diagnostic market are segmented on the basis of disease type, test type, end user and geography
On the basis of disease type, the autoimmune disease diagnostic market is segmented into:
- Systemic Autoimmune Disease diagnostics
- Rheumatoid Arthritis
- Ankylosing Spondylitis
- Systemic Lupus Erythematosus
- Some Others
- Localized autoimmune disease diagnostics
- Multiple Sclerosis
- Type 1 diabetes
- Hashimoto’s thyroiditis
- Idiopathic Thrombocytopenic purpura
The high patient awareness level and large procedure volumes are the reasons that localized autoimmune disease diagnostics is dominating the overall market. Though the initiatives taken by government for patients suffering from rheumatoid arthritis and systemic lupus erythematosus will aid in the growth of systemic autoimmune disease diagnostics segment.
On the basis of test type, the global autoimmune disease diagnostic market is segmented into:
- Antinuclear Antibody Tests
- Autoantibody Tests
- Complete Blood Count
- C-reactive Protein
On the basis of end user, the global autoimmune disease diagnostics market is segmented into
- Diagnostics Centers
- Research Laboratories
The technological advancements in the North America region driving the autoimmune disease diagnostics market
The regional segmentation of autoimmune disease diagnostics market by Coherent Market Insights comprises North America, Europe, Asia Pacific, Africa and rest of the world. North America is of the largest revenue contributor in the global autoimmune disease diagnostics industry. This is mainly attributed to rising incidence of some of the common autoimmune diseases like rheumatoid arthritis and type1 diabetes. The increase in funding by government and private sector, increasing regulatory scenario monitored by World Health Organization (WHO), and technological advancements are some of the factors which are driving growth of the autoimmune disease diagnostics market in the North America region. Asia Pacific is projected to be a fast emerging region in the global autoimmune disease diagnostic market.
Request to view table of content @ https://www.coherentmarketinsights.com/ongoing-insight/toc/419
The introduction of novel biomarkers in the market will aid in the growth of autoimmune disease diagnostic market
The key players operating the autoimmune disease diagnostics market are Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories, Euroimmun, Inova Diagnostics, Roche Diagnostics, Siemens Healthcare, A. Menarini Diagnostics, Adaptive Biotechnologies, AESKU Diagnostics, and many others. The government agencies of various countries are increasing their healthcare spending to provide better health care services, and the introduction of novel biomarkers in the research area, owing for ample opportunity for the key players, which in-turn will boost the autoimmune diseases diagnostic market.
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity